| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/04/2012 | CN101912532B External traditional Chinese medicine preparation for treating burns, scalds and frostbite |
| 01/04/2012 | CN101912528B Chinese medicinal ointment for healing postoperative wound surface of anorectal diseases |
| 01/04/2012 | CN101904986B Compound aloetic bacteriostatic traditional Chinese medicine film and preparation method thereof |
| 01/04/2012 | CN101879255B Medicinal preparation used for treating frostbite and having thrombolysis effect |
| 01/04/2012 | CN101869618B Chinese medicinal acne-removal mixture for treating acne |
| 01/04/2012 | CN101822839B Preparation of nanometer structure lipid carrier by using seal oil as liquid-phase substrate and application |
| 01/04/2012 | CN101780145B Medical stone mineral health-care product |
| 01/04/2012 | CN101722313B Method for preparing nanometer silver solution |
| 01/04/2012 | CN101606988B Anti-loss and hair-growing preparation of six ingredients, preparation method and quality testing method thereof |
| 01/04/2012 | CN101601771B Orally-taken Chinese herb preparation for treating acne and preparation method thereof |
| 01/04/2012 | CN101444551B Rhizoma atractylodis arborinol inclusion compound, medicinal combination thereof and preparation method |
| 01/04/2012 | CN101384246B External preparation for skin containing flavanone derivative |
| 01/04/2012 | CN101347422B Uses of salvianolic acid A in preventing and/or treating diabetes and complication |
| 01/04/2012 | CN101322750B Novel use of Cistanche tubulosa extract |
| 01/04/2012 | CN101301368B Medicinal liquor for treating comedo |
| 01/04/2012 | CN101138543B Centella asiatica partial film forming gel composition and uses thereof |
| 01/03/2012 | US8088825 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/03/2012 | US8088762 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/03/2012 | US8088742 Polyol-glycoside compositions for the skin |
| 01/03/2012 | US8088383 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
| 01/03/2012 | US8088377 Human monoclonal antibodies against CD30 |
| 01/03/2012 | CA2576256C Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
| 01/03/2012 | CA2547322C An aerosol apparatus containing a composition for applying simultaneously several topical stimuli |
| 01/03/2012 | CA2524525C Novel pyridopyrazines and use thereof as kinase modulators |
| 01/03/2012 | CA2514558C Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 01/03/2012 | CA2514407C Thienopyrimidine compounds and use thereof |
| 01/03/2012 | CA2489128C 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
| 01/03/2012 | CA2488565C Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 01/03/2012 | CA2480423C Truncated 24 kda basic fibroblast growth factor |
| 01/03/2012 | CA2466286C Composition and method |
| 01/03/2012 | CA2457719C Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 01/03/2012 | CA2455972C N6-benzyl and phenyl substituted adenines and their use as cosmetics, pharmaceutical preparations and plant growth regulators |
| 01/03/2012 | CA2453243C Treatment of nail infections with no |
| 01/03/2012 | CA2452151C Use of cyclopamine, an inducer of the differentiation and apoptosis of the basal cell carcinoma (bcc) cells, in the treatment of bcc's and other tumors that use the hedgehog/smoothened pathway for proliferation of apoptosis |
| 01/03/2012 | CA2428728C Combination antiperspirant and antimicrobial compositions |
| 01/03/2012 | CA2395684C Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/03/2012 | CA2264562C Sustained peptide-release formulation |
| 01/03/2012 | CA2210998C Inhibition of neovascularization using vegf-specific oligonucleotides |
| 12/29/2011 | WO2011163466A1 Regulation of skin pigmentation by neuregulin-1 (nrg-1) |
| 12/29/2011 | WO2011162416A1 Agent for suppressing the formation of abnormal skin cells caused by exposure to light |
| 12/29/2011 | WO2011162300A1 Crystal of fused pyridine compound salt |
| 12/29/2011 | WO2011162274A1 Isoquinoline derivative |
| 12/29/2011 | WO2011160826A1 Botulinum toxin therapy |
| 12/29/2011 | WO2011160632A1 Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors |
| 12/29/2011 | WO2011097549A9 Treatment skin disorders |
| 12/29/2011 | WO2011097081A3 Methods and compositions for oxygenation of skin to treat skin disorders |
| 12/29/2011 | WO2011094749A3 Small molecule inhibitors that block assembly of the tgf-beta signaling complex |
| 12/29/2011 | WO2011091084A3 Stabilized proteases for use in skin care |
| 12/29/2011 | WO2011064402A3 Acacia macrostachya seed extract and compositions containing same |
| 12/29/2011 | WO2011064401A3 Vigna unguiculata seed extract and compositions containing same |
| 12/29/2011 | WO2010132882A8 Sublingual dexmedetomidine compositions and methods of use thereof |
| 12/29/2011 | WO2010129138A3 Phosphorylated and phosphonated pyrone analogs for therapeutic treatment |
| 12/29/2011 | US20110319808 Antimicrobial composition |
| 12/29/2011 | US20110319805 Topical composition for treating the skin |
| 12/29/2011 | US20110319491 Anhydrous depigmenting compositions comprising, within the fatty phase thereof, a solubilized phenolic compound and a retinoid |
| 12/29/2011 | US20110319489 Enhanced stability peracid compositions |
| 12/29/2011 | US20110319486 Stabilized ascorbic acid solutions; method of use thereof; process for their obtention; and compositions comprising the same |
| 12/29/2011 | US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |
| 12/29/2011 | US20110319471 Lna antagonists targeting the androgen receptor |
| 12/29/2011 | US20110319468 Cyclic amine compounds |
| 12/29/2011 | US20110319465 Estrogen receptor modulators and uses thereof |
| 12/29/2011 | US20110319445 Heteroaryl antagonists of prostaglandin d2 receptors |
| 12/29/2011 | US20110319442 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| 12/29/2011 | US20110319431 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 12/29/2011 | US20110319420 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor |
| 12/29/2011 | US20110319405 Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors |
| 12/29/2011 | US20110319390 6-Aminoisoquinoline Compounds |
| 12/29/2011 | US20110319382 Compositions comprising a calcium channel blocker or a calmodulin blocker for use in the removal of hyperplastic skin lesions |
| 12/29/2011 | US20110319368 Once daily formulations of tetracyclines |
| 12/29/2011 | US20110319363 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 12/29/2011 | US20110319350 Glycoside compounds and pharmaceutical compositions thereof |
| 12/29/2011 | US20110319348 Brassinosteroids in treating prostatic hyperplasia and androgenic alopecia |
| 12/29/2011 | US20110319330 Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion Injury |
| 12/29/2011 | US20110319327 Polypeptides Homologous to VEGF and BMP1 |
| 12/29/2011 | US20110319321 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof |
| 12/29/2011 | US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1 |
| 12/29/2011 | US20110318434 Acne Vulgaris Treatment Regimen |
| 12/29/2011 | US20110318433 Soothing pharmaceutical or cosmetic composition comprising a peptide that activates hmg-coa reductase |
| 12/29/2011 | US20110318428 Treatment solution for treating wounds, in particular for liquid wound treatment |
| 12/29/2011 | US20110318421 Surface functionalized ceramic nanoparticles |
| 12/29/2011 | US20110318404 Wound Dressing, Methods and Apparatus For Making Same and Storage and Use Thereof |
| 12/29/2011 | US20110318403 Preparation and Use of Pouteria Lucuma Extract |
| 12/29/2011 | US20110318401 Treatment of leg ulcers using placenta derived collagen biofabric |
| 12/29/2011 | US20110318400 Skin Care Product |
| 12/29/2011 | US20110318396 Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide |
| 12/29/2011 | US20110318393 Substituted Pyrazole Compounds |
| 12/29/2011 | US20110318362 Novel card proteins involved in cell death regulation |
| 12/29/2011 | US20110318340 Deglycosylated antibodies |
| 12/29/2011 | US20110318319 ACTIVATION and AGGREGATION OF HUMAN PLATELETS AND FORMATION OF PLATELET GELS BY NANOSECOND PULSED ELECTRIC FIELDS |
| 12/29/2011 | US20110318315 Mesenchymal stem cells and uses therefor |
| 12/29/2011 | US20110318314 Mesenchymal stem cells and uses therefor |
| 12/29/2011 | US20110318303 Il-10 and methods of treating ocular and other diseases |
| 12/29/2011 | US20110318278 Foamable suspension gel |
| 12/29/2011 | DE102010032149A1 Nano-Hydrogele für die therapeutische und nichttherapeutische Behandlung, insbesondere zur Therapie von Stresszuständen und Regeneration geschädigter Zellsysteme (Nano-Shuttle-System) Nano-hydrogels for the therapeutic and non-therapeutic treatment, in particular for the treatment of stress conditions and regeneration of damaged cell systems (nano-shuttle system) |
| 12/29/2011 | CA2802895A1 Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors |
| 12/28/2011 | EP2399904A1 Process for the preparation of pleuromutilins |
| 12/28/2011 | EP2399903A1 Ccr9 inhibitors and methods of use thereof |
| 12/28/2011 | EP2399648A2 Cosmetic composition and use of same |
| 12/28/2011 | EP2399601A1 Botulinum toxin therapy |
| 12/28/2011 | EP2398489A2 Composition comprising n2 - (1-oxohexadecyl) - lysyl - valyl - lysine for treating rosacea and its symptoms |